How are rituximab and bendamustine administered for cold agglutinin disease?
For cold agglutinin disease (CAD), rituximab and bendamustine may be combined as a first-line therapy. These chemotherapy medications are typically given together to help reduce the number of immune cells that produce the harmful autoantibodies Show Full Answer
How are rituximab and bendamustine administered for cold agglutinin disease?
For cold agglutinin disease (CAD), rituximab and bendamustine may be combined as a first-line therapy. These chemotherapy medications are typically given together to help reduce the number of immune cells that produce the harmful autoantibodies attacking your red blood cells.
Both medications are usually administered through intravenous (IV) infusion, meaning they're delivered directly into your bloodstream through a vein. The specific dosing schedule and duration of treatment will be determined by your healthcare provider based on your individual needs and response to therapy.
It's worth noting that while chemotherapy drugs are often associated with cancer treatment, they can be effective for CAD because they target the immune cells responsible for the autoimmune response causing your anemia.
March 31
Join
Your Privacy Choices
